Clinical trial · Observational
Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy
NCT07055711CI-TRIAL-00091919active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Peripheral Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Peripheral Neuropathic Pain | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Douleur Neuropathique 4 (DN4) Questionnaire
- timeFrame
- 6 Month
- description
- The DN4 questionnaire is used to assess the neuropathic pain, if the score is \> 4 it indicates the neuropathic pain is present while \<3 than is unlikely.
- measure
- visual analog scale
- timeFrame
- 6 Months
- description
- The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and \> 75 is consider as severe pain.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
- Maximum age
- 51 Years
Show eligibility criteria text
Inclusion Criteria: * Females who have completed chemotherapy at least o1 year prior to study. * Aged 29-51. * Females who is currently employed. * Females who have done chemotherapy for stage 1,2,3. * Females who underwent chemotherapy cycles 6-8. * Females who are willing to participate in the study Exclusion Criteria: * Females suffering from psychiatric conditions such as anxiety and depression. * Females suffering from diabetes. * Females who have active cancer. * Females with mastectomy. * Absent from treatment for more than 2 weeks will be excluded from the study.
References
Publications (0)
Data not yet available
No reference posted for this study.